Patents by Inventor Hanh N. Nguyen

Hanh N. Nguyen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11497757
    Abstract: Described herein in part are silanol based therapeutic payloads comprising a silanol terminus, a divalent spacer moiety, and a drug moiety capable of effecting a target cell or tissue.
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: November 15, 2022
    Assignee: BlinkBio, Inc.
    Inventors: Hanh N. Nguyen, Leslie O. Ofori, Jutta Wanner, Douglas S. Werner
  • Patent number: 11291731
    Abstract: Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: April 5, 2022
    Assignee: BlinkBio, Inc.
    Inventors: Kenneth W. Foreman, Hanh N. Nguyen, Leslie O. Ofori, Jutta Wanner, Douglas S. Werner
  • Publication number: 20190290771
    Abstract: Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.
    Type: Application
    Filed: February 6, 2018
    Publication date: September 26, 2019
    Inventors: Kenneth W. Foreman, Hanh N. Nguyen, Leslie O. Ofori, Jutta Wanner, Douglas S. Werner
  • Patent number: 10293053
    Abstract: Described herein in part are silanol based therapeutic payloads comprising a silanol terminus, a divalent spacer moiety, and a drug moiety capable of effecting a target cell or tissue.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: May 21, 2019
    Assignee: BlinkBio, Inc.
    Inventors: Hanh N. Nguyen, Leslie O. Ofori, Jutta Wanner, Douglas S. Werner
  • Publication number: 20190111142
    Abstract: Described herein in part are silanol based therapeutic payloads comprising a silanol terminus, a divalent spacer moiety, and a drug moiety capable of effecting a target cell or tissue.
    Type: Application
    Filed: December 18, 2018
    Publication date: April 18, 2019
    Applicants: BlinkBio, Inc., BlinkBio, Inc.
    Inventors: Hanh N. Nguyen, Leslie O. Ofori, Jutta Wanner, Douglas S. Werner
  • Patent number: 10064880
    Abstract: Described herein in part are silanol based therapeutic payloads comprising a silanol terminus, a divalent spacer moiety, and a drug moiety capable of effecting a target cell or tissue.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: September 4, 2018
    Assignee: BlinkBio, Inc.
    Inventors: Hanh N. Nguyen, Leslie O. Ofori, Jutta Wanner, Douglas S. Werner
  • Publication number: 20180200273
    Abstract: Described herein in part are silanol based therapeutic payloads comprising a silanol terminus, a divalent spacer moiety, and a drug moiety capable of effecting a target cell or tissue.
    Type: Application
    Filed: March 15, 2018
    Publication date: July 19, 2018
    Inventors: Hanh N. Nguyen, Leslie O. Ofori, Jutta Wanner, Douglas S. Werner
  • Patent number: 9931407
    Abstract: Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.
    Type: Grant
    Filed: April 3, 2017
    Date of Patent: April 3, 2018
    Assignee: BlinkBio, Inc.
    Inventors: Kenneth W. Foreman, Hanh N. Nguyen, Leslie O. Ofori, Jutta Wanner, Douglas S. Werner
  • Publication number: 20170202970
    Abstract: Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.
    Type: Application
    Filed: April 3, 2017
    Publication date: July 20, 2017
    Inventors: Kenneth W. Foreman, Hanh N. Nguyen, Leslie O. Ofori, Jutta Wanner, Douglas S. Werner